Publications
- Blood pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II.receptor and neprilysin.Commentray on::Lancet 375,2010,1255-12662010 | First Faculty of Medicine
- Hemoglobin variability does not predict mortalilty in European hemodialysis patients?Commentary on:AJKD 56,2010,1082-10942010 | First Faculty of Medicine
- Clinical features, outcomes, and response to corticosteroid treatment of acute tubulointerstitial nephritis: a single centre retrospective cohort study in Czech Republic2023 | First Faculty of Medicine, Third Faculty of Medicine
- Biomarkers of fibrosis, kidney tissue injury and inflammation may predict severity and outcome of renal ANCA - associated vasculitis2023 | First Faculty of Medicine
- Terapeutické možnosti blokády komplementu v léčbě atypického hemolyticko-uremického syndromu2023 | First Faculty of Medicine
- Biologická léčba u nemocných s AL amyloidózou2023 | First Faculty of Medicine
- Budesonid potvrdil efekt v léčbě IgA nefropatie ve studii NefIgArd: konec éry systémových kortikosteroidů?2023 | First Faculty of Medicine
- Biologická léčba u systémových amyloidóz2023 | First Faculty of Medicine
- Vybrané doporučené postupy v nefrologii2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Expert opinion on the cooperation of diabetologists and internists with nephrologists in the care of patients with chronic kidney diseases +12022 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
Loading network view...